One in 10 cancer patients denied drugs recommended by their doctor, study finds
Photo credit: Sriram Subramaniam, NCI Recently presented by Paul Workman (Institute of Cancer Research, ICR, London, UK) at a Westminster Forum on drug access (25 April 2019, London, UK) a new Cancer drug manifesto describes calls to action in response to the views of researchers and patients.The ICR’s survey found that 12% of patients had experienced a delay in receiving the cancer treatment recommended by their doctor, with 9% being denied a drug entirely. One fifth of patients had tried to enroll in clinical trials for new treatments but only half had been successfully enrolled. Other findings from the survey include...